ALGS - Aligos Therapeutics, Inc. Common Stock

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
9.61 0.77 (8.01%)	---	---	---	---	0.77 (8.01%)	0.17 (1.75%)	0.17 (1.75%)

Aligos Therapeutics Inc is a clinical stage biopharmaceutical company. It is engaged in developing novel therapeutics to address unmet medical needs in viral and liver diseases, including chronic hepatitis B and coronaviruses, and therapeutics for nonalcoholic steatohepatitis (NASH). The company's pipeline includes ALG-010133, ALG-000184, ALG-020572 and ALG-055009, among others.

Category: BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)

Market Period: AfterHours

Earnings & Ratios

Basic EPS:: -1.53
Diluted EPS:: -1.53
Basic P/E:: -6.7843
Diluted P/E:: -6.7843
RSI(14) 1m:: 59.43
VWAP:: 10.33
RVol:: 1.4497

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	10.2 -0.11 (-1.07%)	Oct 15 15:55
60m	Price increase 60m	10.38 +0.54 (+5.49%)	Oct 15 15:49
1m	Price increase 1m	10.12 +0.19 (+1.91%)	Oct 15 15:21
1m	Price decrease 1m	9.74 -0.14 (-1.42%)	Oct 15 14:24
1m	Price increase 1m	9.83 +0.12 (+1.27%)	Oct 15 12:58